Literature DB >> 33023910

When Should Asymptomatic Persons Be Tested for COVID-19?

Audrey N Schuetz1, Peera Hemarajata2, Ninad Mehta3, Sheldon Campbell4,5, Stephanie Mitchell6, Elizabeth Palavecino7, Susan Butler-Wu8, Melissa B Miller9.   

Abstract

On 24 August 2020, the Centers for Disease Control and Prevention (CDC) updated its website to highlight that asymptomatic individuals, even those with exposure to a COVID-19-positive contact, do not necessarily need to be tested unless they have medical conditions associated with increased risk of severe illness from COVID-19. The CDC subsequently updated its guidance on 19 September 2020 to support testing of asymptomatic persons, including close contacts of persons with documented SARS-CoV-2 infection. In this editorial, the American Society for Microbiology Clinical and Public Health Microbiology Committee's Subcommittee on Laboratory Practices comments on testing of asymptomatic individuals relative to current medical knowledge of the virus and mitigation measures. Specific points are provided concerning such testing when undertaking contact tracing and routine surveillance. Limitations to consider when testing asymptomatic persons are covered, including the need to prioritize testing of contacts of positive COVID-19 cases. We urge the CDC to consult with primary stakeholders of COVID-19 testing when making such impactful changes in testing guidance.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; asymptomatic testing; contact tracing; surveillance

Mesh:

Year:  2020        PMID: 33023910      PMCID: PMC7771439          DOI: 10.1128/JCM.02563-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Initial Evaluation of a Mobile SARS-CoV-2 RT-LAMP Testing Strategy.

Authors:  Christina M Newman; Mitchell D Ramuta; Matthew T McLaughlin; Roger W Wiseman; Julie A Karl; Dawn M Dudley; Miranda R Stauss; Robert J Maddox; Andrea M Weiler; Mason I Bliss; Katrina N Fauser; Luis A Haddock; Cecilia G Shortreed; Amelia K Haj; Molly A Accola; Anna S Heffron; Hailey E Bussan; Matthew R Reynolds; Olivia E Harwood; Ryan V Moriarty; Laurel M Stewart; Chelsea M Crooks; Trent M Prall; Emma K Neumann; Elizabeth D Somsen; Corrie B Burmeister; Kristi L Hall; William M Rehrauer; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  J Biomol Tech       Date:  2021-09

2.  At-home sample collection is an effective strategy for diagnosis and management of symptomatic and asymptomatic SARS-CoV-2 carriers.

Authors:  Devon P Humphreys; Kathleen M Gavin; Kaylan M Olds; Marc P Bonaca; Timothy A Bauer
Journal:  BMC Infect Dis       Date:  2022-05-09       Impact factor: 3.667

3.  A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva.

Authors:  Robert Warneford-Thomson; Parisha P Shah; Patrick Lundgren; Jonathan Lerner; Jason Morgan; Antonio Davila; Benjamin S Abella; Kenneth Zaret; Jonathan Schug; Rajan Jain; Christoph A Thaiss; Roberto Bonasio
Journal:  Elife       Date:  2022-05-09       Impact factor: 8.713

4.  Sociodemographic and Policy Factors Associated with the Transmission of COVID-19: Analyzing Longitudinal Contact Tracing Data from a Northern Chinese City.

Authors:  Han Liu; Zai Liang; Shiyong Zhang; Lihua Liu
Journal:  J Urban Health       Date:  2022-05-31       Impact factor: 5.801

5.  COVID-19 Case Investigation and Contact Tracing in the US, 2020.

Authors:  R Ryan Lash; Patrick K Moonan; Brittany L Byers; Robert A Bonacci; Kimberly E Bonner; Matthew Donahue; Catherine V Donovan; Heather N Grome; Julia M Janssen; Reed Magleby; Heather P McLaughlin; James S Miller; Caroline Q Pratt; Jonathan Steinberg; Kate Varela; Greta L Anschuetz; Paul R Cieslak; Veronica Fialkowski; Aaron T Fleischauer; Clay Goddard; Sara Jo Johnson; Michelle Morris; Jill Moses; Allison Newman; Lauren Prinzing; Alana C Sulka; Puthiery Va; Matthew Willis; John E Oeltmann
Journal:  JAMA Netw Open       Date:  2021-06-01

6.  Initial evaluation of a mobile SARS-CoV-2 RT-LAMP testing strategy.

Authors:  Christina M Newman; Mitchell D Ramuta; Matthew T McLaughlin; Roger W Wiseman; Julie A Karl; Dawn M Dudley; Miranda R Stauss; Robert J Maddox; Andrea M Weiler; Mason I Bliss; Katrina N Fauser; Luis A Haddock; Cecilia G Shortreed; Amelia K Haj; Molly A Accola; Anna S Heffron; Hailey E Bussan; Matthew R Reynolds; Olivia E Harwood; Ryan V Moriarty; Laurel M Stewart; Chelsea M Crooks; Trent M Prall; Emma K Neumann; Elizabeth D Somsen; Corrie B Burmeister; Kristi L Hall; William M Rehrauer; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  medRxiv       Date:  2021-02-27

7.  The effectiveness of visual triaging and testing of suspected COVID-19 cases in primary care setting in Saudi Arabia.

Authors:  Abuobieda Abdalrouf; Alaa Ibrahim; Mohammed Abdulmogith; Attiat Yousif; Nawaf Al Okeil; Azzam Al Otaibi; Saad Albattal; Abood AlAbood; Medhat Maher; Abdelaziz AlRasheed; Mostafa Kofi
Journal:  J Family Med Prim Care       Date:  2021-11-29

8.  Serological and RT-PCR Surveillance for COVID-19 in an Asymptomatic US Army Trainee Population.

Authors:  Shilpa Hakre; Aaron D Sanborn; Stephen W Krauss; Jennifer L Burns; Kenya N Jackson; Melanie D McCauley; Brittany L Ober Shepherd; Samantha McHenry; Shauna L Stahlman; Elizabeth J Bianchi; Joanna Freeman; Jason Ouellette; Jeremiah Stubbs; Crystal Brigantti; Tara L Hall; Milford H Beagle; Paul O Kwon; Jason A Pieri; Timothy R Frambes; Clinton K Murray; Steven B Cersovsky; Kayvon Modjarrad; Sheila A Peel; Paul T Scott
Journal:  Open Forum Infect Dis       Date:  2021-07-29       Impact factor: 3.835

Review 9.  Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Authors:  Yunyun Quan; Li Li; Zhujun Yin; Shilong Chen; Jing Yi; Jirui Lang; Lu Zhang; Qianhua Yue; Junning Zhao
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

10.  Control of an outbreak of COVID-19 at a tertiary hospital in Taiwan.

Authors:  Fang-Fang Hsu; Chia-Jui Yang; Mao-Song Tsai; Hsih-Yeh Tsai; Hong-An Chen; Chun-Hsing Liao
Journal:  J Microbiol Immunol Infect       Date:  2022-08-08       Impact factor: 10.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.